top of page
.png)
Search
Beyond Rituximab: Obinutuzumab Redefines Treatment Resistant Membranous Nephropathy
Obinutuzumab offers a promising next-generation therapy for rituximab-resistant membranous nephropathy, achieving high remission rates and durable B-cell depletion.
Priyadarshini John DM
1 day ago7 min read
The Unasked Questions of Sexual Health in Nephrology Clinics
Reproductive & sexual health in CKD is often overlooked in nephrology. Explore risks, hormonal disruption, and the critical communication gap in nephrology care.
Priti Meena, MD
3 days ago7 min read
Can Dulaglutide Modify the Proteomic Signature of CKD Progression? Impacts Beyond Glycemic Control
Dulaglutide may slow CKD progression by modulating inflammatory and fibrotic pathways beyond glucose control.
sophiaambruso
Apr 253 min read
bottom of page